UroMems wins FDA STeP nod for smart implant that treats SUI
UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy.
Source: massdevice.com
Stay updated with breaking news from Pierre Mozer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy.
/PRNewswire/ -- UroMems, a global company developing breakthrough, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it...